Search

Search Results
Results 6721 - 6730 of 6753 for Alternative therapy
  • News - 25 Feb 2010
    EpiCept Corporation today announced operating and financial results for the fourth quarter and year ended December 31, 2009, and provided an update on Ceplene® and several of the Company’s key product...
  • News - 16 Apr 2004
    Any discussion of health care runs the risk of deteriorating into generalities. So let me be specific: We must reduce wait times. Canadians need to know, Wherever they live, how long it takes to get...
  • Drug - 18 May 2026
    Consumer Medicine Information (CMI) about Cordarone X intended for persons living in Australia.
  • Drug - 4 Mar 2026
    Consumer Medicine Information (CMI) about Eprex intended for persons living in Australia.
  • Drug - 27 Feb 2026
    Consumer Medicine Information (CMI) about Prezista intended for persons living in Australia.
  • Drug - 27 Feb 2026
    Consumer Medicine Information (CMI) about Prezcobix intended for persons living in Australia.
  • Drug - 19 Jan 2026
    Consumer Medicine Information (CMI) about Symtuza intended for persons living in Australia.
  • Drug - 24 Nov 2025
    Consumer Medicine Information (CMI) about Briviact intended for persons living in Australia.
  • Drug - 13 Nov 2025
    Consumer Medicine Information (CMI) about Lincocin intended for persons living in Australia.
  • Drug - 17 Oct 2025
    Consumer Medicine Information (CMI) about Doxylin intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.